Somatostatin receptor imaging of small cell lung cancer (SCLC) by means of 111In-DTPA octreotide scintigraphy
- 31 December 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (2), 184-188
- https://doi.org/10.1016/0959-8049(94)00467-j
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Somatostatin receptor imaging in small cell lung cancer using 111In-DTPA-octreotideNuclear Medicine Communications, 1993
- Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1993
- Validation of Somatostatin Receptor Scintigraphy in the Localization of Neuroendocrine TumorsActa Oncologica, 1993
- Somatostatin receptors are present in small‐cell but not in non‐small‐cell primary lung carcinomas: Relationship to EGF‐receptorsInternational Journal of Cancer, 1990
- Small cell lung cancerBritish Journal of Cancer, 1989
- LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATINThe Lancet, 1989
- Prognostic value of pretreatment carcinoembryonic antigen, neuron-specific enolase, and creatine kinase-BB levels in sera of patients with small cell lung cancerCancer, 1988
- In vitro and in vivo inhibition of human small cell lung carcinoma (NCl-H69) growth by a somatostatin analogueBiochemical and Biophysical Research Communications, 1988
- SOMATOSTATIN INHIBITS RAPID CENTROSOMAL SEPARATION AND CELL PROLIFERATION INDUCED BY EPIDERMAL GROWTH FACTOR.Endocrinology, 1982
- Small-Cell Carcinoma of the Lung: Combined Chemotherapy and RadiationAnnals of Internal Medicine, 1978